Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

CAS Tsis Yog: 475207-59-1
Cov mis mos molecular: C28H24ClF3N4O6S
Molecular phaus: 637.02700
EINECS TSIS YOG: 641-758-8
MDL TSIS YOG: MFCD14635213
Khoom Piav Qhia:
Khoom Npe: Sorafenib tosylate CAS TSIS: 475207-59-1
Lub ntsiab lus:
Bay 43-9006;
4- [4-[[4-chloro-3- (trifluoromethyl) phenyl] carbamoylamino] phenoxy] -N-methylpyridine-2-carboxamide, 4-methylbenzenesulfonic acid;
Nexavar;
Tshuaj& Lub Cev Muaj Zog:
Tshwm sim: Dawb mus rau dawb-dawb crystalline hmoov
Kev Ntsuas: ≥99.00%
Ceev: 1.454 g/cm3
Kub Point: 523.3 ℃ ntawm 760 mmHg
Flash Point: 270.3 ℃
Cov Ntaub Ntawv Kev Nyab Xeeb:
Cov Lus Qhia Risk: R36/37/38
Cov Lus Hais Txog Kev Nyab Xeeb: S28-26
HS Code: 29159000
Sorafenibtosylate, tshuaj hu ua 4- {4- [({[4-chloro-3-(trifluoromethyl) phenyl] amino} carbonyl) amino] phenoxy} -N-methylpyridine-2-formamide p-toluene sulfonate, lub npe lag luam Nexavar, Nws yog thawj qhov tsim los ntawm Chemicalbook Ear Pharmaceutical Company hauv Tebchaws Yelemees. Sorafenib p-toluenesulfonate yog ntau yam kinase inhibitor uas tuaj yeem siv los kho kab mob xws li mob qog noj ntshav. Thaum lub Kaum Ob Hlis 2005, nws tau pom zoo los ntawm FDA hauv Tebchaws Meskas thawj zaug ua thawj kab tshuaj rau kev kho mob qog noj ntshav lub raum zoo. Thaum lub Yim Hli 2009, nws tau pom zoo los ntawm Lub Xeev Khoom Noj thiab Tshuaj Yeeb Tshuaj thawj zaug hauv Suav teb.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!
Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.
Cim npe nrov: sorafenib tosylate cas 475207-59-1, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag